CJ CheilJedang

Last updated January 21, 2026

Innovation Areas

2,168

Inventors

Collaborations

Nucleoside analogue and quinic acid formulations: CJ CheilJedangRecent Research Landscape

Engineering specific molecular scaffolds and excipient matrices to stabilize viral and parasitic inhibitors. This controls the chemical integrity and bio-availability of active pharmaceutical ingredients.

What technical problems is CJ CheilJedang addressing in Nucleoside analogue and quinic acid formulations?

Inadequate intracellular viral replication inhibition

(7)evidences

The cluster addresses the inability of existing treatments to effectively inhibit viral replication and parasitic coccidial infections. Overcoming these biological threats provides a technical advantage in host survival and therapeutic efficacy.

Bacteriophage environmental degradation

(3)evidences

The keywords highlight the need for novel excipients to maintain distribution and storage stability. Solving this prevents the loss of antibacterial potency during the supply chain.